Healthia Ltd
ASX:HLA
Intrinsic Value
Healthia Ltd. is a holding company engages in the operation and expansion of podiatry and physiotherapy clinics, and Business-to-Business businesses in Australia. [ Read More ]
The intrinsic value of one HLA stock under the Base Case scenario is 1.827 AUD. Compared to the current market price of 1.795 AUD, Healthia Ltd is Undervalued by 2%.
Valuation Backtest
Healthia Ltd
Run backtest to discover the historical profit from buying and selling HLA stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Healthia Ltd
Current Assets | 36.8m |
Cash & Short-Term Investments | 5.6m |
Receivables | 13.2m |
Other Current Assets | 18.1m |
Non-Current Assets | 359.1m |
Long-Term Investments | 21k |
PP&E | 85m |
Intangibles | 267.3m |
Other Non-Current Assets | 6.8m |
Current Liabilities | 52.3m |
Accounts Payable | 15.5m |
Accrued Liabilities | 10.3m |
Short-Term Debt | 2m |
Other Current Liabilities | 24.5m |
Non-Current Liabilities | 190.5m |
Long-Term Debt | 145.9m |
Other Non-Current Liabilities | 44.7m |
Earnings Waterfall
Healthia Ltd
Revenue
|
252.6m
AUD
|
Cost of Revenue
|
-20.6m
AUD
|
Gross Profit
|
231.9m
AUD
|
Operating Expenses
|
-202.1m
AUD
|
Operating Income
|
29.9m
AUD
|
Other Expenses
|
-24.4m
AUD
|
Net Income
|
5.5m
AUD
|
Free Cash Flow Analysis
Healthia Ltd
What is Free Cash Flow?
HLA Profitability Score
Profitability Due Diligence
Healthia Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Healthia Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
HLA Solvency Score
Solvency Due Diligence
Healthia Ltd's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Score
Healthia Ltd's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HLA Price Targets Summary
Healthia Ltd
According to Wall Street analysts, the average 1-year price target for HLA is 1.8 AUD .
Shareholder Return
HLA Price
Healthia Ltd
Average Annual Return | 41.85% |
Standard Deviation of Annual Returns | 33.23% |
Max Drawdown | -64% |
Market Capitalization | 251.6m AUD |
Shares Outstanding | 140 423 008 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Healthia Ltd. is a holding company engages in the operation and expansion of podiatry and physiotherapy clinics, and Business-to-Business businesses in Australia. The company is headquartered in Bowen Hills, Queensland. The company went IPO on 2018-09-11. The company operates an integrated portfolio of health businesses, which include My FootDr, Allsports Physiotherapy, Extend Rehabilitation, iOrthotics and DBS Medical Supplies. My FootDr Podiatry Clinics has over 103 podiatry clinics and shoe stores that is engaged in footwear retailing. Allsports Physiotherapy provides physiotherapy services throughout Brisbane. Extend Rehabilitation provides therapies for hand and upper arm. Its iOrthotics manufactures orthotic design software, 3D printing and other technologies and provides orthotic solutions for over 100 podiatry clinics in Australia. DBS Medical Supplies provide supplies to podiatrists, hospitals, medical centers, nursing homes and allied health professionals throughout Australia, as well as New Zealand, the South Pacific and Hong Kong. DBS offer a range of products including podiatry equipment, surgical instruments, orthotic materials, clinic consumables and foot and nail care products.
Contact
IPO
Employees
Officers
The intrinsic value of one HLA stock under the Base Case scenario is 1.827 AUD.
Compared to the current market price of 1.795 AUD, Healthia Ltd is Undervalued by 2%.